Featured Editorial
-
Who Decides When The Comparator Changes?
10/22/2026
Clinical trial comparator sourcing can affect patient treatment and study design. Learn when comparator changes become clinical decisions and who should own them.
-
Is Your Supply Chain Ready For The End Of Class VI?
10/21/2026
Revisions to USP <87> and <88> update biological reactivity testing — changes that are especially important for companies that rely on single-use technology.
-
Why Shelf Life Should Shape Global Country Activation
10/21/2026
Shelf life can shape global country activation strategy, helping clinical supply teams reduce regulatory risk, resupply challenges, relabeling and enrollment delays.
-
Three Months Too Late: How Late Decisions Create Clinical Supply Challenges
10/20/2026
Many clinical supply challenges arise not from gaps in protocol information, but from operational implications recognized too late to influence decisions, as experts explain here.
-
The Hidden Work Between Protocol And Execution: Translating Requirements Into Supply Strategy
10/20/2026
Understanding protocol requirements is only part of the execution challenge. Here, experts explain how intent becomes operational plans, system configurations, and supply strategy.
-
Clinical Trial Supply In The EU And U.K.: A Regulatory Guide
10/20/2026
EU and U.K. clinical trial rules are evolving separately. Here’s what sponsors need to consider across QP release, labeling, importation, and supply continuity.
-
Clinical Supply Chains Need To Solve Problems Before They Happen
10/19/2026
Learn how clinical supply teams can anticipate enrollment changes, manage inventory risks, respond to shipment delays, and make trade-offs to protect clinical trial supply.
-
How New Models Could Improve Trial Enrollment Forecasts
10/16/2026
New statistical and machine learning models could make clinical trial enrollment forecasts more adaptive, helping teams account for uncertainty and changing site performance.
-
Can Site Enrollment Data Improve Clinical Trial Forecasts?
10/15/2026
Site enrollment data can sharpen clinical trial supply forecasts, helping teams adjust inventory, resupply, and manufacturing decisions before demand shifts become costly.
-
Can Standardizing Protocols Improve Clinical Supply Execution?
10/14/2026
M11 may standardize protocol information, but as experts explain here, successful clinical supply execution depends on much more than what’s in the protocol.